Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q1 2018 call → NOWe need answer YES/NO based on transcript. Need determine if management describes currently in middle of copying a part of its own business that already works into additional places where same demand already visible. Need parse. Transcript: Doug Bryant discusses Sofia 2 placements, Solana, Savanna. "Sofia 2 was an absolute hit and we placed as many analyzers on three-year contracts as we could make in the quarter, enlarging our Sofia installed base to over 31,000 analyzers globally." That's growth within existing footprint? Not copying a proven unit into additional places? Maybe "Sofia" is product, placements are sales, not standing up copies of a business unit. Also "we're adding a six fully automated manufacturing line with a capacity of up to 30 million additional Sofia test cartridges per year" - that is adding manufacturing capacity, not copying a proven unit into additional places with demand already identified? It is expanding capacity due to demand. But question asks "copying a part of its own business that is already working into additional places where same demand is already visible" - e.g., opening new sites, new markets, new channels. Management mentions "movement of patients away from traditional healthcare settings" and Sofia in alternate site settings. But no specific "we are standing up additional instances" of a proven unit. Also integration of Triage/BNP: "U.S. is done. We expect Europe to be finished in August and we expect to be live in China by January, 2019." That is about integrating acquired businesses into distribution, not copying a proven unit? It is expanding sales/distribution to new regions. But is that a "proven instance" already works? The acquired businesses have revenue. They are taking over distribution in Europe/China. Demand already identified? Not exactly. Need answer NO likely. The question is very specific: management conveys one coherent situation with proven instance, copies being stood up now, demand already identified at destination, replication large relative to company. The transcript does not clearly have that. There is mention of "we're adding a six fully automated manufacturing line" - that's capacity expansion, not new instances of a business unit. Also "we expect to add a couple more Solana assays shortly" - product line extensions, not copies.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.